Featured News
More News
Dean Minor's message for Diabetes Awareness Month and congratulations to the SDRC
November is Diabetes Awareness Month! On this occassion, Dean Minor of the Stanford School of Medicine shared thoughts and hope for the future of diabetes research at Stanford through the Diabetes Research Center.
Support, education, advocacy boost CGM use among youths with type 1 diabetes
The percentage of adolescents and young adults with type 1 diabetes using continuous glucose monitoring at 10 diabetes clinics increased by 21% following multi-level interventions, according to a study published in Clinical Diabetes.
Steps towards simultaneously treating diabetes and fatty liver disease
Type 2 diabetes melilites (T2DM) is increasing in prevalence, currently affecting about 1 in 10 people. Normally, cells use sugar (glucose) for energy, and insulin enables the sugar to enter the cells.
Insulin resistance doubles risk of major depressive disorder, Stanford study finds
About 1 in 3 American adults has insulin resistance, a silent time bomb that doubles their risk for serious depression, Stanford scientists have learned.
Diabetes, obesity and … the primary cilia?
Ask any high school biology student to draw a picture of a mammalian cell and they'll likely start with a rough circle (the cell membrane) enclosing the nucleus, mitochondria and other subcellular structures necessary for life.
A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...